BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22056593)

  • 1. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of haemorrhagic risk in acute coronary syndromes].
    Merino A; Roldán I; Marín F; Worner F;
    Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 6. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 8. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 9. Stabilizing unstable plaque in acute coronary syndromes: implications for cardiac surgical patients.
    Weber MM; McErlean ES
    Crit Care Nurse; 2000 Aug; 20(4):78-91. PubMed ID: 11876339
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Road mapping ATLAS ACS 2: are we there yet?
    Armstrong PW; Harrington RA
    Eur Heart J; 2012 Oct; 33(20):2510-2. PubMed ID: 22297122
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thrombocytopenia in the acute coronary syndrome.
    Matthai WH
    Curr Opin Hematol; 2010 Sep; 17(5):398-404. PubMed ID: 20703115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.
    Vavalle JP; Rao SV
    Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.
    Halim SA; Rao SV
    Curr Drug Targets; 2011 Nov; 12(12):1831-5. PubMed ID: 21718235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
    Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding associated with the management of acute coronary syndromes.
    De Silva K; Myat A; Cotton J; James S; Gershlick A; Stone GW
    Heart; 2017 Apr; 103(7):546-562. PubMed ID: 28087588
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombotic treatment after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):231. PubMed ID: 25964963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.